Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms. (2019)
Attributed to:
Addressing the funding gap to advance early stage healthcare research at the University of Sheffield
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.16193
PubMed Identifier: 31525819
Publication URI: http://europepmc.org/abstract/MED/31525819
Type: Journal Article/Review
Volume: 187
Parent Publication: British journal of haematology
Issue: 3
ISSN: 0007-1048